Decision of the EEA Joint Committee No 14/2011 of 1 April 2011 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement
Date: 2011-04-01
Institutions: EEA Joint Committee
Subjects: European Economic Area, health risk, market approval, plant health product, revision of an agreement




L_2011171EN.01001101.xml










30.6.2011   


EN


Official Journal of the European Union


L 171/11








            DECISION OF THE EEA JOINT COMMITTEE
         
No 14/2011
of 1 April 2011
         
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement


THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area, as amended by the Protocol adjusting the Agreement on the European Economic Area, hereinafter referred to as ‘the Agreement’, and in particular Article 98 thereof,

Whereas:







(1)


Annex II to the Agreement was amended by Decision of the EEA Joint Committee No 128/2010 of 10 December 2010 (1).












(2)


Commission Directive 2010/5/EU of 8 February 2010 amending Directive 98/8/EC of the European Parliament and of the Council to include acrolein as an active substance in Annex I thereto (2) is to be incorporated into the Agreement.












(3)


Commission Directive 2010/8/EU of 9 February 2010 amending Directive 98/8/EC of the European Parliament and of the Council to include warfarin sodium as an active substance in Annex I thereto (3) is to be incorporated into the Agreement.












(4)


Commission Directive 2010/9/EU of 9 February 2010 amending Directive 98/8/EC of the European Parliament and of the Council to extend the inclusion in Annex I thereto of the active substance aluminium phosphide releasing phosphine to product type 18 as defined in Annex V thereto (4) is to be incorporated into the Agreement.












(5)


Commission Directive 2010/10/EU of 9 February 2010 amending Directive 98/8/EC of the European Parliament and of the Council to include brodifacoum as an active substance in Annex I thereto (5) is to be incorporated into the Agreement.












(6)


Commission Directive 2010/11/EU of 9 February 2010 amending Directive 98/8/EC of the European Parliament and of the Council to include warfarin as an active substance in Annex I thereto (6) is to be incorporated into the Agreement.












(7)


Commission Decision 2010/122/EU of 25 February 2010 amending, for the purposes of adapting to scientific and technical progress, the Annex to Directive 2002/95/EC of the European Parliament and of the Council as regards an exemption for an application of cadmium (7) is to be incorporated into the Agreement,





HAS DECIDED AS FOLLOWS:



Article 1
Chapter XV of Annex II to the Agreement shall be amended as follows:






(1)


the following indents shall be added in point 12n (Directive 98/8/EC of the European Parliament and of the Council):






‘—



32010 L 0005: Commission Directive 2010/5/EU of 8 February 2010 (OJ L 36, 9.2.2010, p. 24),










—



32010 L 0008: Commission Directive 2010/8/EU of 9 February 2010 (OJ L 37, 10.2.2010, p. 37),










—



32010 L 0009: Commission Directive 2010/9/EU of 9 February 2010 (OJ L 37, 10.2.2010, p. 40),










—



32010 L 0010: Commission Directive 2010/10/EU of 9 February 2010 (OJ L 37, 10.2.2010, p. 44),










—



32010 L 0011: Commission Directive 2010/11/EU of 9 February 2010 (OJ L 37, 10.2.2010, p. 47).’;














(2)


the following indent shall be added in point 12q (Directive 2002/95/EC of the European Parliament and of the Council):






‘—



32010 D 0122: Commission Decision 2010/122/EU of 25 February 2010 (OJ L 49, 26.2.2010, p. 32).’.










Article 2
The texts of Directives 2010/5/EU, 2010/8/EU, 2010/9/EU, 2010/10/EU, 2010/11/EU and Decision 2010/122/EU in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.


Article 3
This Decision shall enter into force on 2 April 2011, provided that all the notifications under Article 103(1) of the Agreement have been made to the EEA Joint Committee (*1).


Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.




Done at Brussels, 1 April 2011.


For the EEA Joint Committee


The Acting President

Gianluca GRIPPA
            





(1)  
            OJ L 85, 31.3.2011, p. 11.

(2)  
            OJ L 36, 9.2.2010, p. 24.

(3)  
            OJ L 37, 10.2.2010, p. 37.

(4)  
            OJ L 37, 10.2.2010, p. 40.

(5)  
            OJ L 37, 10.2.2010, p. 44.

(6)  
            OJ L 37, 10.2.2010, p. 47.

(7)  
            OJ L 49, 26.2.2010, p. 32.

(*1)  No constitutional requirements indicated.